Román, L. R., Hänggeli, K. P. A., Hemphill, A., Horcajo, P., Collantes-Fernández, E., Ortega-Mora, L. M., & Boubaker, G. (2024, June). TaqMan-quantitative PCR assays applied in Neospora caninum knock-outs generated through CRISPR-Cas9 allow to determine the copy numbers of integrated dihydrofolate reductase-thymidylate synthase drug selectable markers. Frontiers in Cellular and Infection Microbiology.
Chicago Style (17th ed.) CitationRomán, Laura Rico-San, Kai Pascal Alexander Hänggeli, Andrew Hemphill, Pilar Horcajo, Esther Collantes-Fernández, Luis Miguel Ortega-Mora, and Ghalia Boubaker. "TaqMan-quantitative PCR Assays Applied in Neospora Caninum Knock-outs Generated Through CRISPR-Cas9 Allow to Determine the Copy Numbers of Integrated Dihydrofolate Reductase-thymidylate Synthase Drug Selectable Markers." Frontiers in Cellular and Infection Microbiology Jun. 2024.
MLA (9th ed.) CitationRomán, Laura Rico-San, et al. "TaqMan-quantitative PCR Assays Applied in Neospora Caninum Knock-outs Generated Through CRISPR-Cas9 Allow to Determine the Copy Numbers of Integrated Dihydrofolate Reductase-thymidylate Synthase Drug Selectable Markers." Frontiers in Cellular and Infection Microbiology, Jun. 2024.
